Back to School: How biopharma can reboot drug development. Access exclusive analysis here

TTP889: Phase I data

In 2 placebo-controlled U.S. Phase I trials in a total of 90 volunteers,

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE